Home / Resources / Articles / Smoking Harms Kidney Function in Type 2’s

Smoking Harms Kidney Function in Type 2’s

Nov 7, 2006

People with type 2 diabetes who smoke cigarettes are more than twice as likely as non-smokers to have impaired kidney function, research shows. The findings underscore the importance of helping diabetics kick the habit, Dr. Mauro Cignarelli of the University of Foggia in Italy. While smoking is known to damage the kidneys of individuals with type 1 diabetes, its effects have not been studied as extensively in people with type 2 diabetes.

To investigate, the researchers looked at a measure of kidney function called glomerular filtration rate (GFR) in 158 smokers and 158 never-smokers, all of whom had type 2 diabetes. GFR measures how quickly the tiny blood vessels in the kidneys are able to filter waste products out of the blood.

Twelve percent of the non-smokers had a low GFR, the researchers found, compared to 21 percent of the smokers, making smokers 2.2 times more likely to have impaired kidney function. The effects were strongest in those who had had diabetes for the shortest time; in this group, smokers were more than four times as likely as non-smokers to have low GFR, indicating impaired kidney function.

The researchers also found higher levels of tissue-damaging byproducts of metabolism known as oxygen free radicals in the smokers, which they suggest might have helped fuel the damage.

"While waiting for prospective studies to clarify the relationship between smoking and kidney damage in diabetic patients, efforts to help type 2 diabetic patients to quit smoking are strongly recommended," Cignarelli and colleagues conclude.

Diabetes Care, November 2006.


Dr. Bernstein will be doing another live teleconference call soon. If you would like to ask a question or just register for the free teleconference call, just go to http://www.askdrbernstein.com and register. There were over 600 people on the last call. More info at http://www.diabetes911.net


See clinical data on the sustained benefits of BYETTA for the treatment of type 2 diabetes. BYETTA delivers sustained glycemic control, with most patients losing weight, and simple, fixed BID dosing before morning and evening meals. Click here: